Trump's Executive Order Paves the Way for Psychedelic Treatments
Published on: April 18, 2026, 10:07 p.m. | Source: Devdiscourse
U.S. President Donald Trump signed an executive order to expedite the review of psychedelic drugs like ibogaine for treating mental health conditions. With backing from veterans and key advocates, the order aims to reclassify these substances and earmarks $50 million for federal research into ibogaine.
